---
title: "Keymed Biosciences plans RMB share listing on Shanghai STAR Market"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/296363752.md"
description: "Keymed Biosciences' board approved a plan to issue RMB-denominated shares for listing on the Shanghai STAR Market. The initiative is in early stages, with no regulatory filings yet submitted. Execution depends on market conditions, shareholder approval, final board sign-off, and regulatory clearances. Investors were cautioned that the listing plan may change or be dropped."
datetime: "2026-08-19T13:32:04.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/296363752.md)
  - [en](https://longbridge.com/en/news/296363752.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/296363752.md)
generator: "portal-rs"
---

# Keymed Biosciences plans RMB share listing on Shanghai STAR Market

-   Keymed Biosciences’ board on Aug. 19, 2026 backed a plan to issue RMB-denominated ordinary shares for listing on Shanghai’s Sci-Tech Board. \* The move remains at an early stage with no regulatory filings made. \* Execution depends on market conditions, shareholder approval at a general meeting, board sign-off on a final plan, regulatory clearances. \* Investors were warned the Shanghai listing plan could change or be dropped. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Keymed Biosciences Inc. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260819-12291024), on August 19, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### Related Stocks

- [02162.HK](https://longbridge.com/en/quote/02162.HK.md)

## Related News & Research

- [05:13 ETKeymed Biosciences Announces 2026 H1 Results and Business Updates](https://longbridge.com/en/news/296594656.md)
- [Keymed Biosciences Announces 2026 H1 Results and Business Updates | LKFT Stock News](https://longbridge.com/en/news/296505276.md)
- [Impact Therapeutics schedules board meeting to review interim results](https://longbridge.com/en/news/296324936.md)
- [Rjvan Holdings files HKEX next-day disclosure return, share capital rises by 20,682,112 shares at HKD 0.39 each](https://longbridge.com/en/news/296244081.md)
- [Cloudbreak Pharma sets board meeting to review interim results, consider dividend](https://longbridge.com/en/news/296368760.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**